Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 110 entries
Sorted by: Best Match Show Resources per page
[Early invalidation--a multifactorial process. Comprehensive report on a socioepidemiologic study of possible causes of early retirement in Baden-Württemberg].

Das Offentliche Gesundheitswesen

Fassmann H, Kentner M, Passenberger J, Wasilewski R.
PMID: 2934652
Offentl Gesundheitswes. 1985 Nov;47(11):546-50.

No abstract available.

Presynaptic mechanisms of neuronal plasticity and their role in epilepsy.

Frontiers in cellular neuroscience

Meier JC, Meier J, Semtner M, Winkelmann A, Wolfart J.
PMID: 24987332
Front Cell Neurosci. 2014 Jun 17;8:164. doi: 10.3389/fncel.2014.00164. eCollection 2014.

Synaptic communication requires constant adjustments of pre- and postsynaptic efficacies. In addition to synaptic long term plasticity, the presynaptic machinery underlies homeostatic regulations which prevent out of range transmitter release. In this minireview we will discuss the relevance of...

Do overweight workers profit by workplace health promotion, more than their normal-weight peers? Evaluation of a worksite intervention.

Journal of occupational medicine and toxicology (London, England)

Mache S, Jensen S, Linnig S, Jahn R, Steudtner M, Ochsmann E, Preuß G.
PMID: 26236389
J Occup Med Toxicol. 2015 Aug 01;10:28. doi: 10.1186/s12995-015-0068-3. eCollection 2015.

BACKGROUND: Worksite health promotion programs have been identified as strongly effective in decreasing body weight and increasing awareness and change in health behavior. Aim of this study is to determine the effects of a multi-component intervention in workplace health...

First-line treatment of chronic lymphocytic leukemia: role of alemtuzumab.

OncoTargets and therapy

Schweighofer CD, Wendtner CM.
PMID: 20616957
Onco Targets Ther. 2010 Jun 24;3:53-67. doi: 10.2147/ott.s3099.

The CD52-targeting antibody alemtuzumab is established in clinical practice with convincing activity in relapsed and refractory chronic lymphocytic leukemia (CLL), particularly in patients with high-risk features and adverse prognosis. In the CAM307 study alemtuzumab was tested and finally approved...

How to Write an Effective Materials and Methods Section for Clinical Studies.

Clinical spine surgery

Stenson JF, Foltz C, Lendner M, Vaccaro AR.
PMID: 30256241
Clin Spine Surg. 2019 Jun;32(5):208-209. doi: 10.1097/BSD.0000000000000722.

The Materials and methods section of a research paper is oftentimes the first and easiest part to write. It details the steps taken to answer a research hypothesis, the success of which determines whether or not the study can...

Ductal Mucus Obstruction and Reduced Fluid Secretion Are Early Defects in Chronic Pancreatitis.

Frontiers in physiology

Balázs A, Balla Z, Kui B, Maléth J, Rakonczay Z, Duerr J, Zhou-Suckow Z, Schatterny J, Sendler M, Mayerle J, Kühn JP, Tiszlavicz L, Mall MA, Hegyi P.
PMID: 29896115
Front Physiol. 2018 May 29;9:632. doi: 10.3389/fphys.2018.00632. eCollection 2018.

No abstract available.

Correction: An essential role of the mouse synapse-associated protein Syap1 in circuits for spontaneous motor activity and rotarod balance.

Biology open

von Collenberg CR, Schmitt D, Rü Licke T, Sendtner M, Blum R, Buchner E.
PMID: 32071078
Biol Open. 2020 Feb 18;9(2). doi: 10.1242/bio.048942.

No abstract available.

How to Write an Effective Results Section.

Clinical spine surgery

Snyder N, Foltz C, Lendner M, Vaccaro AR.
PMID: 31145152
Clin Spine Surg. 2019 Aug;32(7):295-296. doi: 10.1097/BSD.0000000000000845.

Developing a well-written research paper is an important step in completing a scientific study. This paper is where the principle investigator and co-authors report the purpose, methods, findings, and conclusions of the study. A key element of writing a...

Absence of Plekhg5 Results in Myelin Infoldings Corresponding to an Impaired Schwann Cell Autophagy, and a Reduced T-Cell Infiltration Into Peripheral Nerves.

Frontiers in cellular neuroscience

Lüningschrör P, Slotta C, Heimann P, Briese M, Weikert UM, Massih B, Appenzeller S, Sendtner M, Kaltschmidt C, Kaltschmidt B.
PMID: 32733205
Front Cell Neurosci. 2020 Jul 07;14:185. doi: 10.3389/fncel.2020.00185. eCollection 2020.

Inflammation and dysregulation of the immune system are hallmarks of several neurodegenerative diseases. An activated immune response is considered to be the cause of myelin breakdown in demyelinating disorders. In the peripheral nervous system (PNS), myelin can be degraded...

Ciliary Neurotrophic Factor Enhances the Rate of Oligodendrocyte Generation.

Molecular and cellular neurosciences

Barres BA, Burne JF, Holtmann B, Thoenen H, Sendtner M, Raff MC.
PMID: 8954629
Mol Cell Neurosci. 1996 Aug;8(2):146-56. doi: 10.1006/mcne.1996.0053.

Although ciliary neurotrophic factor (CNTF) is a potent survival factor for many types of neurons and glial cells in vitro, there is currently no evidence that it participates in normal development. Here we show that CNTF greatly enhances the...

P052 National Registration of Patients With Inflammatory Bowel Disease in Brazil on Behalf of GEDIIB.

The American journal of gastroenterology

Mikaell F, Ligia S, Adriana A, Roberto KJ, Rogerio P, Giedre H, Abel Q, Genoile S, Carlos S, Mauro B, Sender M, Jaqueline B, Catiane N, Kauyza S, Antonio M, José P, Eduardo V, Rogerio SH, Renata F.
PMID: 34848639
Am J Gastroenterol. 2021 Dec 01;116:S13-S14. doi: 10.14309/01.ajg.0000798808.75513.51.

No abstract available.

Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis.

JAMA neurology

Johnson JO, Chia R, Miller DE, Li R, Kumaran R, Abramzon Y, Alahmady N, Renton AE, Topp SD, Gibbs JR, Cookson MR, Sabir MS, Dalgard CL, Troakes C, Jones AR, Shatunov A, Iacoangeli A, Al Khleifat A, Ticozzi N, Silani V, Gellera C, Blair IP, Dobson-Stone C, Kwok JB, Bonkowski ES, Palvadeau R, Tienari PJ, Morrison KE, Shaw PJ, Al-Chalabi A, Brown RH, Calvo A, Mora G, Al-Saif H, Gotkine M, Leigh F, Chang IJ, Perlman SJ, Glass I, Scott AI, Shaw CE, Basak AN, Landers JE, Chiò A, Crawford TO, Smith BN, Traynor BJ, Smith BN, Ticozzi N, Fallini C, Gkazi AS, Topp SD, Scotter EL, Kenna KP, Keagle P, Tiloca C, Vance C, Troakes C, Colombrita C, King A, Pensato V, Castellotti B, Baas F, Ten Asbroek ALMA, McKenna-Yasek D, McLaughlin RL, Polak M, Asress S, Esteban-Pérez J, Stevic Z, D'Alfonso S, Mazzini L, Comi GP, Del Bo R, Ceroni M, Gagliardi S, Querin G, Bertolin C, van Rheenen W, Rademakers R, van Blitterswijk M, Lauria G, Duga S, Corti S, Cereda C, Corrado L, Sorarù G, Williams KL, Nicholson GA, Blair IP, Leblond-Manry C, Rouleau GA, Hardiman O, Morrison KE, Veldink JH, van den Berg LH, Al-Chalabi A, Pall H, Shaw PJ, Turner MR, Talbot K, Taroni F, García-Redondo A, Wu Z, Glass JD, Gellera C, Ratti A, Brown RH, Silani V, Shaw CE, Landers JE, Dalgard CL, Adeleye A, Soltis AR, Alba C, Viollet C, Bacikova D, Hupalo DN, Sukumar G, Pollard HB, Wilkerson MD, Martinez EM, Abramzon Y, Ahmed S, Arepalli S, Baloh RH, Bowser R, Brady CB, Brice A, Broach J, Campbell RH, Camu W, Chia R, Cooper-Knock J, Ding J, Drepper C, Drory VE, Dunckley TL, Eicher JD, England BK, Faghri F, Feldman E, Floeter MK, Fratta P, Geiger JT, Gerhard G, Gibbs JR, Gibson SB, Glass JD, Hardy J, Harms MB, Heiman-Patterson TD, Hernandez DG, Jansson L, Kirby J, Kowall NW, Laaksovirta H, Landeck N, Landi F, Le Ber I, Lumbroso S, MacGowan DJL, Maragakis NJ, Mora G, Mouzat K, Murphy NA, Myllykangas L, Nalls MA, Orrell RW, Ostrow LW, Pamphlett R, Pickering-Brown S, Pioro EP, Pletnikova O, Pliner HA, Pulst SM, Ravits JM, Renton AE, Rivera A, Robberecht W, Rogaeva E, Rollinson S, Rothstein JD, Scholz SW, Sendtner M, Shaw PJ, Sidle KC, Simmons Z, Singleton AB, Smith N, Stone DJ, Tienari PJ, Troncoso JC, Valori M, Van Damme P, Van Deerlin VM, Van Den Bosch L, Zinman L, Landers JE, Chiò A, Traynor BJ, Angelocola SM, Ausiello FP, Barberis M, Bartolomei I, Battistini S, Bersano E, Bisogni G, Borghero G, Brunetti M, Cabona C, Calvo A, Canale F, Canosa A, Cantisani TA, Capasso M, Caponnetto C, Cardinali P, Carrera P, Casale F, Chiò A, Colletti T, Conforti FL, Conte A, Conti E, Corbo M, Cuccu S, Dalla Bella E, D'Errico E, DeMarco G, Dubbioso R, Ferrarese C, Ferraro PM, Filippi M, Fini N, Floris G, Fuda G, Gallone S, Gianferrari G, Giannini F, Grassano M, Greco L, Iazzolino B, Introna A, La Bella V, Lattante S, Lauria G, Liguori R, Logroscino G, Logullo FO, Lunetta C, Mandich P, Mandrioli J, Manera U, Manganelli F, Marangi G, Marinou K, Marrosu MG, Martinelli I, Messina S, Moglia C, Mora G, Mosca L, Murru MR, Origone P, Passaniti C, Petrelli C, Petrucci A, Pozzi S, Pugliatti M, Quattrini A, Ricci C, Riolo G, Riva N, Russo M, Sabatelli M, Salamone P, Salivetto M, Salvi F, Santarelli M, Sbaiz L, Sideri R, Simone I, Simonini C, Spataro R, Tanel R, Tedeschi G, Ticca A, Torriello A, Tranquilli S, Tremolizzo L, Trojsi F, Vasta R, Vacchiano V, Vita G, Volanti P, Zollino M, Zucchi E.
PMID: 34459874
JAMA Neurol. 2021 Oct 01;78(10):1236-1248. doi: 10.1001/jamaneurol.2021.2598.

IMPORTANCE: Juvenile amyotrophic lateral sclerosis (ALS) is a rare form of ALS characterized by age of symptom onset less than 25 years and a variable presentation.OBJECTIVE: To identify the genetic variants associated with juvenile ALS.DESIGN, SETTING, AND PARTICIPANTS: In...

Showing 1 to 12 of 110 entries